Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q1 Loss of $0.20
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.57 +0.22%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.20), versus ($0.03) reported last year. Revenue for the quarter came in at $21.3 million, versus $29.46 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Citi opens downside catalyst watch on Kroger as Walmart price war intensifies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
